Form 4: Enzo Biochem Director Steven J. Pully Acquires Restricted Stock Units

Director Steven J. Pully of Enzo Biochem, Inc. was granted 142,897 restricted stock units, which will vest on the first anniversary of the grant date or upon a change of control event.

Summary

• Steven J. Pully, a director at Enzo Biochem, Inc., acquired 142,897 restricted stock units on January 16, 2025.
• These restricted stock units will vest on the earlier of January 16, 2026, or a change of control event.
• The acquisition was a grant, with a price of $0 per unit.
• Following the transaction, Pully's total holdings include 239,992 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of granting stock units to a director, which is generally viewed positively as it aligns interests. There are no negative implications or surprises.

Positives

• The grant of restricted stock units to a director aligns their interests with the long-term success of the company.
• The vesting schedule encourages the director's continued service and commitment to the company.

Risks

• The vesting of the restricted stock units is contingent on time or a change of control, which could create uncertainty.

Future Outlook

The restricted stock units will vest on the earlier of January 16, 2026, or a change of control event.

Industry Context

This is a standard practice for incentivizing directors and aligning their interests with shareholders in the biotechnology industry.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice in the biotech industry, similar to companies like Regeneron Pharmaceuticals and Gilead Sciences.
• The vesting period of one year is also typical, aligning with industry standards for long-term incentives.
• The change of control provision is a standard clause in such agreements, protecting the director's interests in the event of a merger or acquisition.

Stakeholder Impact

• Shareholders may view this positively as it aligns the director's interests with the company's long-term performance.
• The grant of restricted stock units does not have an immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

restricted stock units, director, insider trading, beneficial ownership, equity, Enzo Biochem, stock grant, vesting